Abstract
We examined whether administration of delta 9-tetrahydrocannabinol (THC) induces the expression of Fos protein or not in the rat brain. A single administration of 3.2 and 10 mg/kg THC produced a dose-dependent and significant increase in Fos-immunoreactive cells in the striatum, particularly in its dorsomedial portions. The peak increase was reached 2 h after THC treatment and was absent at 8 h. Fos induction was also observed in the nucleus accumbens after administration of 10 mg/kg THC. However, in the globus pallidus, hippocampus and substantia nigra pars reticula, abundant in cannabinoid receptors, there were few or no Fos-immunoreactive cells induced by 10 mg/kg THC. SCH-23390, a selective dopamine D1 receptor antagonist, at 0.32 mg/kg produced a significant block of the effects of THC on Fos expression in the striatum and the nucleus accumbens. Administration of 100 mg/kg (-)-sulpiride, a selective dopamine D2 receptor antagonist, failed to block the effect of THC on Fos expression in both the striatum and the nucleus accumbens. These findings indicate that THC induces the expression of Fos protein and that this expression is mediated at least by dopamine D1 receptors.
References
Mar 3, 1992·European Journal of Pharmacology·I M Maisonneuve, S D Glick
May 1, 1992·Trends in Pharmacological Sciences·G F Koob
Jun 8, 1990·Science·B RusakS P Hunt
Aug 1, 1990·Neuron·J M KornhauserJ S Takahashi
Aug 9, 1990·Nature·L A MatsudaT I Bonner
Jul 1, 1989·Brain Research. Molecular Brain Research·R M GubitsH Yu
Jan 1, 1989·Neuroscience·E CarboniG Di Chiara
Jun 7, 1988·Brain Research·J M Ng Cheong TonE L Gardner
Oct 1, 1987·Nature·M Dragunow, H A Robertson
Dec 15, 1988·Biochemical and Biophysical Research Communications·S L ChangR E Harlan
Jan 26, 1995·Neuroreport·M Glass, M Dragunow
Citations
Jun 17, 1998·Molecular Neurobiology·R E Harlan, M M Garcia
Jan 30, 2008·Psychopharmacology·Deepak Cyril D'SouzaEdward Perry
Jul 18, 2009·European Archives of Psychiatry and Clinical Neuroscience·Deepak Cyril D'SouzaMohini Ranganathan
Sep 28, 1998·Brain Research·I S McGregorG E Hunt
Aug 31, 1999·Life Sciences·F FerrariD Giuliani
Mar 8, 2003·Neuropharmacology·K V AllenP E Mallet
May 9, 2002·Behavioural Brain Research·Glenn E Hunt, Iain S McGregor
Oct 16, 1999·Brain Research. Molecular Brain Research·M Erdtmann-VourliotisV Höllt
Sep 29, 1999·Progress in Neurobiology·P SvenningssonB B Fredholm
Jun 12, 1999·Neuroscience·R AlonsoP Soubrié
Mar 11, 2000·The European Journal of Neuroscience·O ValverdeB P Roques
Jan 16, 2014·Psychopharmacology·Mohini RanganathanDeepak Cyril D'Souza
Mar 23, 2010·Psychiatry Research·Felice IasevoliAndrea de Bartolomeis
Sep 27, 2003·The European Journal of Neuroscience·Belen FerrerAndrea Giuffrida
Mar 12, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Patrik RoserWolfram Kawohl
Dec 15, 2016·Pharmacology, Biochemistry, and Behavior·Tim RuhlGerhard von der Emde
Apr 16, 2009·International Review of Psychiatry·R Andrew SewellDeepak Cyril D'Souza
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Sep 18, 2015·British Journal of Pharmacology·S M Todd, J C Arnold
Feb 12, 1999·Neurobiology of Disease·E L Gardner, S R Vorel